+Compare
PFE
Stock ticker:
NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
214.63B

PFE Price Prediction, Pfizer AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for PFE with price predictions
08:00 PM EDT May 30, 2023

PFE in -2.17% downward trend, falling for three consecutive days on May 30, 2023

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where PFE declined for three days, in of 295 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where PFE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

PFE moved below its 50-day moving average on May 24, 2023 date and that indicates a change from an upward trend to a downward trend.

PFE broke above its upper Bollinger Band on May 23, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PFE entered a downward trend on May 23, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PFE's RSI Oscillator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 31, 2023. You may want to consider a long position or call options on PFE as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PFE just turned positive on May 22, 2023. Looking at past instances where PFE's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PFE advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.126) is normal, around the industry mean (6.114). P/E Ratio (7.496) is within average values for comparable stocks, (30.155). Projected Growth (PEG Ratio) (1.110) is also within normal values, averaging (3.471). PFE has a moderately high Dividend Yield (0.043) as compared to the industry average of (0.027). P/S Ratio (2.342) is also within normal values, averaging (4.008).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PFE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I. Advisor
published Earnings

PFE is expected to report earnings to fall 49.32% to 62 cents per share on August 01

Pfizer PFE Stock Earnings Reports
Q2'23
Est.
$0.62
Q1'23
Beat
by $0.25
Q4'22
Beat
by $0.09
Q3'22
Beat
by $0.34
Q2'22
Beat
by $0.32
The last earnings report on May 02 showed earnings per share of $1.23, beating the estimate of 98 cents. With 43.78M shares outstanding, the current market capitalization sits at 214.63B.
A.I.Advisor
published Dividends

PFE is expected to pay dividends on June 09, 2023

Pfizer PFE Stock Dividends
A dividend of $0.41 per share will be paid with a record date of June 09, 2023, and an ex-dividend date of May 11, 2023. The last dividend of $0.41 was paid on March 03. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 79.62B. The market cap for tickers in the group ranges from 72.83K to 407.67B. LLY holds the highest valuation in this group at 407.67B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -2%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -1%. OTSKF experienced the highest price growth at 5%, while CHJTF experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 49%. For the same stocks of the Industry, the average monthly volume growth was 74% and the average quarterly volume growth was 82%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 28
P/E Growth Rating: 56
Price Growth Rating: 51
SMR Rating: 52
Profit Risk Rating: 59
Seasonality Score: 12 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of vaccines and injectable biologic medicines

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
66 Hudson Boulevard East
Phone
+1 212 733-2323
Employees
83000
Web
https://www.pfizer.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMVP5.370.06
+1.13%
PMV Pharmaceuticals
PNM45.920.38
+0.83%
PNM Resources
FRG29.10-0.01
-0.03%
Franchise Group
BTCY0.69-0.01
-1.43%
Biotricity
APH75.45-1.32
-1.72%
Amphenol Corp

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with JNJ. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
+2.73%
JNJ - PFE
59%
Loosely correlated
+0.45%
MRK - PFE
55%
Loosely correlated
+1.14%
BMY - PFE
50%
Loosely correlated
+1.15%
GILD - PFE
48%
Loosely correlated
+0.84%
AZN - PFE
48%
Loosely correlated
+2.30%
More